Bibliographic references on Probiotics for Kids

(1) Szajewska H, Kołodziej M. Systematic review with meta-analysis: Lactobacillus rhamnosus GG in the prevention of antibiotic-associated diarrhoea in children and adults. Aliment Pharmacol Ther. 2015;42(10):1149-1157. doi:10.1111/apt.13404,

(2 )Sidor, Andrzej & Gramza Michalowska, Anna. (2014). Advanced research on the antioxidant and health benefit of elderberry (Sambucus nigra) in food – a review. Journal of Functional Foods. 18. 10.1016/j.jff.2014.07.012.

(3) Kołodziej M, Szajewska H. Lactobacillus reuteri DSM 17938 in the prevention of antibiotic-associated diarrhoea in children: protocol of a randomised controlled trial. BMJ Open. 2017;7(1): e013928. DOI: 10.1136/bmjopen-2016-013928

(4) Francavilla, R., Lionetti, E., Castellaneta, S., Ciruzzi, F., Indrio, F., Masciale, A., Fontana, C., La Rosa, M.M., Cavallo, L. and Francavilla, A., 2012. Randomised clinical trial: Lactobacillus reuteri DSM 17938 vs. placebo in children with acute diarrhoea – a double-blind study. Alimentary Pharmacology and Therapeutics 36: 363-369.

(5) Dinleyici EC, Dalgic N, Guven S, et al. Lactobacillus reuteri DSM 17938 shortens acute infectious diarrhea in a pediatric outpatient setting. J Pediatr (Rio J). 2015;91:392-396.

(6) Urbanska M, Szajewska H. The efficacy of Lactobacillus reuteri DSM 17938 in infants and children: a review of the current evidence. Eur J Pediatr. 2014;173:1327-1337.

(7) Savino F. et al., (2015), ‘Preventive effects of oral probiotic on infantile colic: a prospective, randomised, blinded, controlled trial using Lactobacillus reuteri DSM 17938’. Benef. Microbes, 6(3):245-251, ePub 8 Dec. 2014.

(8) Weizman Z, Abu-Abed J, Binsztok M. Lactobacillus reuteri DSM 17938 for the Management of Functional Abdominal Pain in Childhood: A Randomized, Double-Blind, Placebo-Controlled Trial. J Pediatr. 2016;174:160-164.e1. doi:10.1016/j.jpeds.2016.04.003

(9) Kalman, D.S., Schwartz, H.I., Alvarez, P. et al. A prospective, randomized, double-blind, placebo-controlled parallel-group dual site trial to evaluate the effects of a Bacillus coagulans-based product on functional intestinal gas symptoms. BMC Gastroenterol 9, 85 (2009).

(10) Rogha M, Esfahani MZ, Zargarzadeh AH. The efficacy of a synbiotic containing Bacillus Coagulans in treatment of irritable bowel syndrome: a randomized placebo-controlled trial. Gastroenterol Hepatol Bed Bench. 2014;7(3):156-163.

(11) Anaya-Loyola MA, Enciso-Moreno JA, Lopez-Ramos JE, Garcia-Marin G, Orozco Alvarez MY, Vega-Garcai AM, Mosqueda J, Garcia-Gutierrez DG, Keller D, Perez-Ramirez IF. Bacillus coagulans GBI-30, 6086 decreases upper respiratory and gastrointestinal tract symptoms in healthy Mexican scholar-aged children by modulating immune-related proteins. (2019) 

(12) Majeed M, Nagabhushanam K, Natarajan S, et al. Bacillus coagulans MTCC 5856 supplementation in the management of diarrhea predominant Irritable Bowel Syndrome: a double blind randomized placebo controlled clinical study. Nutr J. 2016;15:21. Published 2016 Feb 27. doi:10.1186/s12937-016-0140-6

(13) Madempudi, R.S., Ahire, J.J., Neelamraju, J. et al. Randomized clinical trial: the effect of probiotic Bacillus coagulans Unique IS2 vs. placebo on the symptoms management of irritable bowel syndrome in adults. Sci Rep 9, 12210 (2019).

(14) Labellarte, G. and Maher, M. (2019) Tolerance and Effect of a Probiotic Supplement Delivered in Capsule Form. Food and Nutrition Sciences, 10, 626-634. doi: 10.4236/fns.2019.106046.

(15) Lorenzo-Zúñiga V, Llop E, Suárez C, Alvarez B, Abreu L, Espadaler J, et al. I.31, a new combination of probiotics, improves irritable bowel syndrome-related quality of life. World J Gastroenterol. 2014 Jul 14;20(26):8709–16.

(16). McKay DL, Blumberg JB. A review of the bioactivity and potential health benefits of peppermint tea (Mentha piperita L.). Phytother Res. 2006 Aug;20(8):619-33. doi: 10.1002/ptr.1936. PMID: 16767798.

(17) Dolin BJ. Effects of a proprietary Bacillus coagulans preparation on symptoms of diarrhea-predominant irritable bowel syndrome. Methods Find Exp Clin Pharmacol. 2009;31(10):655-659. doi:10.1358/mf.2009.31.10.1441078

(18) Szymański H, Armańska M, Kowalska-Duplaga K, Szajewska H. Bifidobacterium longum PL03, Lactobacillus rhamnosus KL53A, and Lactobacillus plantarum PL02 in the prevention of antibiotic-associated diarrhea in children: a randomized controlled pilot trial. Digestion. 2008;78(1):13-17. doi:10.1159/000151300

(19) Jirapinyo P, Densupsoontorn N, Thamonsiri N, et al. Prevention of antibiotic-associated diarrhea in infants by probiotics. J Med Assoc Thai 2002;85(Suppl 2):S739-42.

(20)Sur D, Manna B, Niyogi SK, et al. Role of probiotic in preventing acute diarrhoea in children: a community-based, randomized, double-blind placebo-controlled field trial in an urban slum. Epidemiol Infect. 2011;139(6):919-926. doi:10.1017/S0950268810001780

(21)Janvier A, Malo J, Barrington KJ. Cohort study of probiotics in a North American neonatal intensive care unit [published correction appears in J Pediatr. 2014 Jun;164(6):1503]. J Pediatr. 2014;164(5):980-985. doi:10.1016/j.jpeds.2013.11.025

(22)Latvala, S., et al. “Health Benefits of a Combination Probiotics; FlorMidabil[TM].” International Journal of Probiotics & Prebiotics, vol. 14, 2019, p. 9+. Gale Academic OneFile

(23)Paineau, Damien & Carcano, Didier & Leyer, Gregory & Darquy, Sylviane & Alyanakian, Marie-Alexandra & Simoneau, Guy & Bergmann, Jean-François & Brassart, Dominique & Bornet, Francis R. J. & Ouwehand, Arthur. (2008). Effects of seven potential probiotic strains on specific immune responses in healthy adults: A double-blind, randomized, controlled trial. FEMS immunology and medical microbiology. 53. 107-13. 10.1111/j.1574-695X.2008.00413.x.

(24)García Trallero O, Herrera Serrano L, Bibián Inglés M, Roche Vallés D, Rodríguez AM. Effect of the administration of a probiotic with a combination of Lactobacillus and Bifidobacterium strains on antibiotic-associated diarrhea. Rev Esp Quimioter. 2019;32(3):268-272.

(25)Zupancic K, Kriksic V, Kovacevic I, Kovacevic D. Influence of Oral Probiotic Streptococcus salivarius K12 on Ear and Oral Cavity Health in Humans: Systematic Review. Probiotics Antimicrob Proteins. 2017;9(2):102-110. doi:10.1007/s12602-017-9261-2

(26) Di Pierro F, Zanvit A, Nobili P, Risso P, Fornaini C. Cariogram outcome after 90 days of oral treatment with Streptococcus salivarius M18 in children at high risk for dental caries: results of a randomized, controlled study. Clin Cosmet Investig Dent. 2015;7:107-113. Published 2015 Oct 3. doi:10.2147/CCIDE.S93066

(27)Cui, X and Wure, G. 2003. The treatment of 62 cases of rotavirus gastroenteritis by Biostime probiotics. Chin J Gen Med 5:53-54.

(28)Jiang X. 2008. Clinical evaluation of Biostime in the treatment of children with persistent diarrhea. The 6th Chin National Conf on Pediatr Microecol 142-145.

(29)Chen L, Ouyang L-J, Liao W-J, Zhang W-H. 2007. Mucous membrane immunity enhanced by taking Biostime probiotics. Chin J Ecol 19:137-141.

(30)Cazzola M, Pham-Thi N, Kerihuel JC, Durand H, Bohbot S. 2010b. Efficacy of a synbiotic supplementation in the prevention of common winter diseases in children: a randomized, double-blind, placebo-controlled pilot study. Ther Adv. Respir Dis 4:271-278.

(31)Jennifer C Dennis-Wall, Tyler Culpepper, Carmelo Nieves, Jr., Cassie C Rowe, Alyssa M Burns, Carley T Rusch, Ashton Federico, Maria Ukhanova, Sheldon Waugh, Volker Mai, Mary C Christman, Bobbi Langkamp-Henken, Probiotics (Lactobacillus gasseri KS-13, Bifidobacterium bifidum G9-1, and Bifidobacterium longum MM-2) improve rhinoconjunctivitis-specific quality of life in individuals with seasonal allergies: a double-blind, placebo-controlled, randomized trial, The American Journal of Clinical Nutrition, Volume 105, Issue 3, March 2017, Pages 758–767,

(32)Kawahara T, Makizaki Y, Oikawa Y, et al. Oral administration of Bifidobacterium bifidum G9-1 alleviates rotavirus gastroenteritis through regulation of intestinal homeostasis by inducing mucosal protective factors. PLoS One. 2017;12(3):e0173979. Published 2017 Mar 27. doi:10.1371/journal.pone.0173979

(33)M. Margreiter, K. Ludl, W. Phleps and S.T. Kaehler.Therapeutic value of a Lactobacillus gasseri and Bifidobacterium longum fixed bacterium combination in acute diarrhea: a randomized, double-blind, controlled clinical trial. 2006; 44: 207-215. doi: 10.5414/CPP44207.

(34)Acidophilus Milk Products: A Review of Potential Benefits to Consumers Gilliland S.E.(1989) Journal of Dairy Science, 72 (10) , pp. 2483-2494.

(35) Lee Y. and Salminen S., (2009), Handbook of Probiotic and Prebiotics. 2nd edition, Hoboken: John Wiley & Sons.
Lindfors K., (2008), ‘Live probiotic Bifidobacterium lactis bacteria inhibit the toxic effects induced by wheat gliadin in epithelial cell culture’. Clin. Exp. Immunol., 152 (3):552-558.

(36) Jirapinyo P, Densupsoontorn N, Thamonsiri N, et al. Prevention of antibiotic-associated diarrhea in infants by probiotics. J Med Assoc Thai 2002;85(Suppl 2):S739-42.

(37) Lönnermark E, Friman V, Lappas G, Sandberg T, Berggren A, Adlerberth I. Intake of Lactobacillus plantarum reduces certain gastrointestinal symptoms during treatment with antibiotics. J Clin Gastroenterol. 2010;44(2):106-112. doi:10.1097/MCG.0b013e3181b2683f

(38) Engelbrektson, Anna & Korzenik, Joshua & Pittler, Arlyn & Sanders, Mary & Klaenhammer, Todd & Leyer, Gregory & Kitts, Christopher. (2009). Probiotics to minimize the disruption of faecal microbiota in healthy subjects undergoing antibiotic therapy. Journal of medical microbiology. 58. 663-70. 10.1099/jmm.0.47615-0.